Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J F de Jonge

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 14, 2016
[The return of the hepatitis delta virus]R Zoutendijk, P J F de Jonge, R A de Man
Alimentary Pharmacology & Therapeutics|June 9, 2007
Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohortP J F DE Jonge, L M M Wolters, E W Steyerberg, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2008
Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adductsP J F De Jonge, P D Siersema, S G J Van Breda, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 3, 2020
Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett's Neoplasia: Endoscopic Findings and Long-Term MortalityS N van Munster, E A Nieuwenhuis, B L A M Weusten, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|July 14, 2016
[The return of the hepatitis delta virus]R Zoutendijk, P J F de Jonge, R A de Man
Alimentary Pharmacology & Therapeutics|June 9, 2007
Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohortP J F DE Jonge, L M M Wolters, E W Steyerberg, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2008
Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adductsP J F De Jonge, P D Siersema, S G J Van Breda, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 3, 2020
Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett's Neoplasia: Endoscopic Findings and Long-Term MortalityS N van Munster, E A Nieuwenhuis, B L A M Weusten, et al.
Pageof 1